AMRN FY 2017 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$181M+39.2% YoY

Gross Profit

$136M75.2% margin

Operating Income

-$46M-25.2% margin

Net Income

-$68M-37.5% margin

EPS (Diluted)

$-5.00

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$33M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$162M

Total Liabilities

$227M

Stockholders' Equity

-$65M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$181M	$130M	+39.2%
Gross Profit	$136M	$96M	+42.2%
Operating Income	-$46M	-$66M	+30.6%
Net Income	-$68M	-$86M	+21.4%